Form CORRESP - Correspondence:
SEC Accession No. 0001213900-17-010240
Filing Date
2017-10-03
Accepted
2017-10-03 14:02:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 10798
  Complete submission text file 0001213900-17-010240.txt   11780
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations